Literature DB >> 32722661

Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning.

Heather E Soder1, Jessica A Cooper2, Paula Lopez-Gamundi1,3,4, Jennifer K Hoots5, Cecilia Nunez5, Victoria M Lawlor2, Scott D Lane1, Michael T Treadway6,7, Margaret C Wardle8.   

Abstract

Effort-related decision-making and reward learning are both dopamine-dependent, but preclinical research suggests they depend on different dopamine signaling dynamics. Therefore, the same dose of a dopaminergic medication could have differential effects on effort for reward vs. reward learning. However, no study has tested how effort and reward learning respond to the same dopaminergic medication within subjects. The current study aimed to test the effect of therapeutic doses of d-amphetamine on effort for reward and reward learning in the same healthy volunteers. Participants (n = 30) completed the Effort Expenditure for Reward Task (EEfRT) measure of effort-related decision-making, and the Probabilistic Reward Task (PRT) measure of reward learning, under placebo and two doses of d-amphetamine (10 mg, and 20 mg). Secondarily, we examined whether the individual characteristics of baseline working memory and willingness to exert effort for reward moderated the effects of d-amphetamine. d-Amphetamine increased willingness to exert effort, particularly at low to intermediate expected values of reward. Computational modeling analyses suggested this was due to decreased effort discounting rather than probability discounting or decision consistency. Both baseline effort and working memory emerged as moderators of this effect, such that d-amphetamine increased effort more in individuals with lower working memory and lower baseline effort, also primarily at low to intermediate expected values of reward. In contrast, d-amphetamine had no significant effect on reward learning. These results have implications for treatment of neuropsychiatric disorders, which may be characterized by multiple underlying reward dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32722661      PMCID: PMC8115674          DOI: 10.1038/s41386-020-0779-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  Amping up effort: effects of d-amphetamine on human effort-based decision-making.

Authors:  Margaret C Wardle; Michael T Treadway; Leah M Mayo; David H Zald; Harriet de Wit
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

Review 2.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

Review 3.  Dopamine in schizophrenia: a review and reconceptualization.

Authors:  K L Davis; R S Kahn; G Ko; M Davidson
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

4.  Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans.

Authors:  Mathias Pessiglione; Ben Seymour; Guillaume Flandin; Raymond J Dolan; Chris D Frith
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

5.  Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction.

Authors:  Viswanath V Venugopalan; Kevin F Casey; Caitlin O'Hara; Jennifer O'Loughlin; Chawki Benkelfat; Lesley K Fellows; Marco Leyton
Journal:  Neuropsychopharmacology       Date:  2011-07-20       Impact factor: 7.853

Review 6.  Dopamine in drug abuse and addiction: results of imaging studies and treatment implications.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; James M Swanson; Frank Telang
Journal:  Arch Neurol       Date:  2007-11

7.  Dopamine Manipulation Affects Response Vigor Independently of Opportunity Cost.

Authors:  Alexandre Zénon; Sophie Devesse; Etienne Olivier
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

8.  Influence of dopaminergically mediated reward on somatosensory decision-making.

Authors:  Burkhard Pleger; Christian C Ruff; Felix Blankenburg; Stefan Klöppel; Jon Driver; Raymond J Dolan
Journal:  PLoS Biol       Date:  2009-07-28       Impact factor: 8.029

9.  Dopamine and light: dissecting effects on mood and motivational states in women with subsyndromal seasonal affective disorder.

Authors:  Elizabeth I Cawley; Sarah Park; Marije aan het Rot; Kimberley Sancton; Chawki Benkelfat; Simon N Young; Diane B Boivin; Marco Leyton
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

10.  Haloperidol impairs learning and error-related negativity in humans.

Authors:  Patrick J Zirnheld; Christine A Carroll; Paul D Kieffaber; Brian F O'Donnell; Anantha Shekhar; William P Hetrick
Journal:  J Cogn Neurosci       Date:  2004 Jul-Aug       Impact factor: 3.225

View more
  7 in total

1.  Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.

Authors:  Mandakh Bekhbat; Zhihao Li; Namrataa D Mehta; Michael T Treadway; Michael J Lucido; Bobbi J Woolwine; Ebrahim Haroon; Andrew H Miller; Jennifer C Felger
Journal:  Mol Psychiatry       Date:  2022-08-04       Impact factor: 13.437

Review 2.  Vigor, Effort-Related Aspects of Motivation and Anhedonia.

Authors:  Michael T Treadway; John D Salamone
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Shared and distinct reward neural mechanisms among patients with schizophrenia, major depressive disorder, and bipolar disorder: an effort-based functional imaging study.

Authors:  Yan-Yu Wang; Yi Wang; Jia Huang; Xi-He Sun; Xi-Zhen Wang; Shu-Xian Zhang; Guo-Hui Zhu; Simon S Y Lui; Eric F C Cheung; Hong-Wei Sun; Raymond C K Chan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-26       Impact factor: 5.760

Review 4.  Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications.

Authors:  Mandakh Bekhbat; Michael T Treadway; Jennifer C Felger
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Acute drug effects differentially predict desire to take dextroamphetamine again for work and recreation.

Authors:  Jennifer K Hoots; Heather E Webber; Cecilia Nunez; Jessica A Cooper; Paula Lopez-Gamundi; Victoria M Lawlor; Scott D Lane; Michael T Treadway; Margaret C Wardle
Journal:  Psychopharmacology (Berl)       Date:  2021-06-17       Impact factor: 4.415

Review 6.  Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder.

Authors:  Yun-Ai Su; Tianmei Si
Journal:  Gen Psychiatr       Date:  2022-02-24

7.  Pharmacological investigations of effort-based decision-making in humans: Naltrexone and nicotine.

Authors:  Cecilia Nunez; Jennifer K Hoots; Scott T Schepers; Michael Bower; Harriet de Wit; Margaret C Wardle
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.